Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$2.66 - $3.45 $32,007 - $41,513
-12,033 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$2.59 - $3.3 $518,872 - $661,112
-200,337 Reduced 94.33%
12,033 $34,000
Q1 2021

May 14, 2021

SELL
$2.99 - $3.58 $1.82 Million - $2.18 Million
-608,726 Reduced 74.14%
212,370 $643,000
Q4 2020

Feb 12, 2021

BUY
$2.9 - $3.3 $112,099 - $127,561
38,655 Added 4.94%
821,096 $2.42 Million
Q2 2020

Aug 14, 2020

SELL
$3.17 - $4.01 $956,648 - $1.21 Million
-301,782 Reduced 27.83%
782,441 $2.61 Million
Q1 2020

May 14, 2020

BUY
$3.45 - $5.33 $255,310 - $394,435
74,003 Added 7.33%
1,084,223 $3.94 Million
Q4 2019

Feb 14, 2020

BUY
$4.68 - $5.79 $242,896 - $300,506
51,901 Added 5.42%
1,010,220 $5.2 Million
Q3 2019

Nov 14, 2019

SELL
$4.73 - $6.4 $1.53 Million - $2.07 Million
-322,785 Reduced 25.2%
958,319 $5.68 Million
Q2 2019

Aug 14, 2019

BUY
$5.35 - $6.8 $435,473 - $553,499
81,397 Added 6.78%
1,281,104 $8.16 Million
Q1 2019

May 15, 2019

BUY
$5.06 - $6.5 $100,714 - $129,376
19,904 Added 1.69%
1,199,707 $6.97 Million
Q4 2018

Feb 14, 2019

SELL
$5.31 - $7.0 $586,829 - $773,598
-110,514 Reduced 8.56%
1,179,803 $7.11 Million
Q3 2018

Nov 14, 2018

SELL
$5.5 - $6.3 $81,042 - $92,830
-14,735 Reduced 1.13%
1,290,317 $7.37 Million
Q2 2018

Aug 10, 2018

BUY
$5.91 - $6.9 $1.72 Million - $2.01 Million
291,126 Added 28.71%
1,305,052 $8 Million
Q1 2018

May 14, 2018

BUY
$6.62 - $7.12 $687,487 - $739,412
103,850 Added 11.41%
1,013,926 $6.77 Million
Q4 2017

Feb 14, 2018

BUY
$6.79 - $7.96 $155,708 - $182,538
22,932 Added 2.58%
910,076 $6.7 Million
Q3 2017

Nov 14, 2017

SELL
$6.47 - $7.21 $577,337 - $643,369
-89,233 Reduced 9.14%
887,144 $6.26 Million
Q2 2017

Aug 14, 2017

BUY
N/A
976,377
976,377 $6.84 Million

Others Institutions Holding CPIX

About CUMBERLAND PHARMACEUTICALS INC


  • Ticker CPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 14,661,900
  • Market Cap $37.8M
  • Description
  • Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...
More about CPIX
Track This Portfolio

Track Ariel Investments, LLC Portfolio

Follow Ariel Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ariel Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ariel Investments, LLC with notifications on news.